EMBC
Embecta Corp.
NasdaqGSUSDEQUITY
Healthcare
DELAYED
Neutral
-6/100
Last price
5.95
▲ 0.07 (1.19%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
5.88
Day high
6.15
Day low
5.80
Volume
1.21M
Market cap
$337.12M
P/E (TTM)
4.05
52W range
2.77 – 14.91
Trailing performance
Returnvs SPY
1W
+3.30%
+1.4%
1M
+2.59%
+1.4%
3M
+86.52%
+82.0%
6M
-32.62%
-50.8%
YTD
-49.92%
-64.2%
1Y
-58.45%
-74.9%
3Y
-60.47%
-142.7%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on EMBC open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
+138.71K
Net buying
Buy transactions
5
145.00K shares
Sell transactions
1
6.29K shares
Net transactions
+6
Buys less sells
Sell : buy shares
0.0 : 1
Mixed
Insider-held shares
1.14M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Sep 4, 26 | MORRIS MILTON MAYO Director |
SELL | 6.29K | $36.97K | Direct |
| Aug 12, 26 | HOMBACH ROBERT J. CPA Director |
BUY | 45.00K | $223.85K | Direct |
| Aug 12, 26 | MANN JEFFREY Z Officer |
BUY | 20.00K | $99.80K | Direct |
| Aug 12, 26 | ELGUICZE JACOB Officer |
BUY | 20.00K | $93.36K | Direct |
| Aug 12, 26 | KURDIKAR DEVDATT Officer and Director |
BUY | 30.00K | $140.94K | Direct |
| Jun 1, 26 | ROTH ANTHONY M. Officer |
STOCK | 30.00K | $0 | Direct |
| Feb 11, 26 | MORRIS MILTON MAYO Director |
STOCK | 22.84K | $0 | Direct |
| Feb 11, 26 | HOMBACH ROBERT J. CPA Director |
STOCK | 22.84K | $0 | Direct |
| Feb 11, 26 | PRANGE KAREN N. Director |
STOCK | 22.84K | $0 | Direct |
| Feb 11, 26 | POMEROY CLAIRE Director |
STOCK | 22.84K | $0 | Direct |
| Feb 11, 26 | ANDERSON CARRIE L Director |
STOCK | 22.84K | $0 | Direct |
| Feb 11, 26 | REIDY CHRISTOPHER R Director |
STOCK | 22.84K | $0 | Direct |
| Nov 26, 25 | CASNER JEAN Officer |
STOCK | 38.78K | $0 | Direct |
| Nov 26, 25 | MANN JEFFREY Z General Counsel |
STOCK | 104.05K | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
CASNER JEAN |
Officer | 84.70K | Stock Award(Grant) |
CURTIS SHAUN |
Officer | 95.32K | Stock Award(Grant) |
ELGUICZE JACOB |
Officer | 309.14K | Purchase |
HOMBACH ROBERT J. CPA |
Director | 109.59K | Purchase |
KURDIKAR DEVDATT |
Officer and Director | 804.92K | Purchase |
MANN JEFFREY Z |
Officer | 262.92K | Purchase |
MELCHER DAVID F. |
Director | 86.68K | Purchase |
POMEROY CLAIRE |
Director | 66.13K | Stock Award(Grant) |
REIDY CHRISTOPHER R |
Director | 70.12K | Stock Award(Grant) |
ROTH ANTHONY M. |
Officer | 78.83K | Stock Award(Grant) |
Fundamentals
Market cap$337.12M
Enterprise value$1.62B
Revenue (TTM)$1.02B
Gross profit$595.10M
EBITDA$281.50M
Net income$87.50M
EPS (TTM)$1.47
Free cash flow$138.20M
Total cash$214.70M
Total debt$1.50B
Book value / share$-10.81
Shares outstanding56.66M
Float54.77M
Short % of float11.77%
Dividend yield0.67%
Beta (5Y)0.83
Valuation & profitability ratios
Trailing P/E4.05
Forward P/E3.38
PEG ratio—
Price / sales—
Price / book—
EV / revenue1.59
EV / EBITDA5.77
Gross margin58.42%
Operating margin23.67%
Profit margin8.59%
Return on equity—
Return on assets12.24%
Debt / equity—
Current ratio1.68
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $1.08B | $1.12B | $1.12B | $1.13B | -3.8% |
| Operating revenue | $1.08B | $1.12B | $1.12B | $1.13B | -3.8% |
| Cost of revenue | $403.60M | $387.90M | $370.90M | $354.60M | +4.0% |
| Gross profit | $676.80M | $735.20M | $749.90M | $774.90M | -7.9% |
| Research & development | $37.30M | $78.80M | $85.20M | $66.90M | -52.7% |
| Selling, general & admin | $332.00M | $365.10M | $341.30M | $294.80M | -9.1% |
| Total operating expense | $380.40M | $450.20M | $525.90M | $406.40M | -15.5% |
| Operating income | $296.40M | $285.00M | $224.00M | $368.50M | +4.0% |
| Net interest income | -$107.30M | -$112.30M | -$107.00M | -$46.20M | +4.5% |
| Pre-tax income | $136.30M | $44.20M | $105.70M | $256.60M | +208.4% |
| Tax provision | $40.90M | -$34.10M | $35.30M | $33.00M | +219.9% |
| Net income | $95.40M | $78.30M | $70.40M | $223.60M | +21.8% |
| Net income to common | $95.40M | $78.30M | $70.40M | $223.60M | +21.8% |
| Basic EPS | 1.64 | 1.36 | 1.23 | 3.92 | +20.6% |
| Diluted EPS | 1.62 | 1.34 | 1.22 | 3.89 | +20.9% |
| EBIT | $243.60M | $156.50M | $212.70M | $302.80M | +55.7% |
| EBITDA | $284.30M | $192.70M | $245.30M | $334.50M | +47.5% |
| Basic shares | 58.31M | 57.57M | 57.24M | 57.04M | +1.3% |
| Diluted shares | 58.91M | 58.33M | 57.70M | 57.48M | +1.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $225.50M | $267.50M | $326.30M | $330.90M | -15.7% |
| Cash & short-term investments | $225.50M | $267.50M | $326.30M | $330.90M | -15.7% |
| Accounts receivable | $145.60M | $193.00M | $16.70M | $22.20M | -24.6% |
| Inventory | $178.60M | $171.50M | $152.10M | $122.80M | +4.1% |
| Total current assets | $631.40M | $761.00M | $749.10M | $664.70M | -17.0% |
| Property, plant & equipment | $257.20M | $290.40M | $300.20M | $301.60M | -11.4% |
| Goodwill & intangibles | $22.40M | $23.70M | $24.70M | $24.60M | -5.5% |
| Total assets | $1.09B | $1.29B | $1.21B | $1.09B | -15.1% |
| Total current liabilities | $261.50M | $374.00M | $353.50M | $301.00M | -30.1% |
| Current debt | $9.50M | $9.50M | $9.50M | $9.50M | 0.0% |
| Long-term debt | $1.39B | $1.57B | $1.59B | $1.60B | -11.3% |
| Total debt | $1.43B | $1.61B | $1.64B | $1.64B | -11.1% |
| Total liabilities | $1.74B | $2.02B | $2.04B | $1.98B | -13.9% |
| Retained earnings | -$445.60M | -$498.60M | -$541.10M | -$577.10M | +10.6% |
| Shareholder equity | -$651.20M | -$738.90M | -$821.70M | -$891.40M | +11.9% |
| Working capital | $369.90M | $387.00M | $395.60M | $363.70M | -4.4% |
| Net tangible assets | -$673.60M | -$762.60M | -$846.40M | -$916.00M | +11.7% |
| Shares issued | 58.50M | 57.71M | 57.33M | 57.06M | +1.4% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $95.40M | $78.30M | $70.40M | $223.60M | +21.8% |
| Depreciation & amortisation | $40.70M | $36.20M | $32.60M | $31.70M | +12.4% |
| Stock-based compensation | $31.60M | $26.30M | $21.50M | $18.70M | +20.2% |
| Change in working capital | -$23.70M | -$47.70M | -$80.00M | $102.60M | +50.3% |
| Operating cash flow | $191.70M | $35.70M | $67.70M | $412.20M | +437.0% |
| Capital expenditure | -$9.30M | -$15.80M | -$26.50M | -$24.00M | +41.1% |
| Investing cash flow | -$9.30M | -$15.80M | -$26.50M | -$24.00M | +41.1% |
| Dividends paid | -$35.00M | -$34.50M | -$34.40M | -$8.60M | -1.4% |
| Financing cash flow | -$226.70M | -$73.40M | -$48.70M | -$48.00M | -208.9% |
| Free cash flow | $182.40M | $19.90M | $41.20M | $388.20M | +816.6% |
| End cash position | $228.60M | $274.20M | $326.50M | $330.90M | -16.6% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $271.70M | $221.80M | $261.20M | $264.00M | $295.50M | +22.5% |
| Operating revenue | $271.70M | $221.80M | $261.20M | $264.00M | $295.50M | +22.5% |
| Cost of revenue | $118.40M | $94.00M | $99.50M | $105.50M | $98.40M | +26.0% |
| Gross profit | $153.30M | $127.80M | $161.70M | $158.50M | $197.10M | +20.0% |
| Research & development | $5.60M | $5.40M | $4.60M | $4.60M | $4.40M | +3.7% |
| Selling, general & admin | $78.60M | $76.20M | $77.60M | $86.90M | $84.40M | +3.1% |
| Total operating expense | $89.00M | $84.90M | $85.40M | $94.20M | $92.10M | +4.8% |
| Operating income | $64.30M | $42.90M | $76.30M | $64.30M | $105.00M | +49.9% |
| Net interest income | -$23.90M | -$22.60M | -$24.10M | -$26.10M | -$26.60M | -5.8% |
| Pre-tax income | $27.60M | $9.50M | $58.90M | $29.00M | $72.20M | +190.5% |
| Tax provision | $6.50M | $13.60M | $14.80M | $2.60M | $26.70M | -52.2% |
| Net income | $21.10M | -$4.10M | $44.10M | $26.40M | $45.50M | +614.6% |
| Net income to common | $21.10M | -$4.10M | $44.10M | $26.40M | $45.50M | +614.6% |
| Basic EPS | 0.36 | -0.07 | 0.75 | 0.45 | 0.78 | +614.3% |
| Diluted EPS | 0.36 | -0.07 | 0.74 | 0.45 | 0.78 | +614.3% |
| EBIT | $51.50M | $32.10M | $83.00M | $55.10M | $98.80M | +60.4% |
| EBITDA | $64.70M | $44.90M | $95.90M | $60.40M | $110.60M | +44.1% |
| Basic shares | 58.48M | 59.30M | 58.80M | 58.67M | 58.49M | -1.4% |
| Diluted shares | 58.51M | 59.40M | 59.29M | 58.87M | 58.49M | -1.5% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $214.70M | $184.90M | $201.30M | $225.50M | $230.60M | +16.1% |
| Cash & short-term investments | $214.70M | $184.90M | $201.30M | $225.50M | $230.60M | +16.1% |
| Accounts receivable | $182.20M | $147.10M | $159.20M | $145.60M | $182.80M | +23.9% |
| Inventory | $214.20M | $192.60M | $181.80M | $178.60M | $189.90M | +11.2% |
| Total current assets | $705.10M | $608.10M | $620.20M | $631.40M | $681.50M | +16.0% |
| Property, plant & equipment | $316.80M | $237.50M | $248.90M | $257.20M | $262.70M | +33.4% |
| Goodwill & intangibles | $87.40M | $21.90M | $22.10M | $22.40M | $22.70M | +299.1% |
| Total assets | $1.27B | $1.03B | $1.06B | $1.09B | $1.16B | +22.9% |
| Total current liabilities | $419.80M | $247.30M | $234.70M | $261.50M | $275.50M | +69.8% |
| Current debt | $139.40M | $9.50M | $9.50M | $9.50M | $9.50M | +1,367.4% |
| Long-term debt | $1.32B | $1.32B | $1.35B | $1.39B | $1.46B | -0.1% |
| Total debt | $1.49B | $1.36B | $1.39B | $1.43B | $1.50B | +9.4% |
| Total liabilities | $1.88B | $1.66B | $1.68B | $1.74B | $1.83B | +13.4% |
| Retained earnings | -$404.30M | -$424.70M | -$411.10M | -$445.60M | -$457.10M | +4.8% |
| Shareholder equity | -$612.70M | -$626.10M | -$613.10M | -$651.20M | -$669.60M | +2.1% |
| Working capital | $285.30M | $360.80M | $385.50M | $369.90M | $406.00M | -20.9% |
| Net tangible assets | -$700.10M | -$648.00M | -$635.20M | -$673.60M | -$692.30M | -8.0% |
| Shares issued | 56.66M | 59.33M | 59.21M | 58.50M | 58.47M | -4.5% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $21.10M | -$4.10M | $44.10M | $26.40M | $45.50M | +614.6% |
| Depreciation & amortisation | $13.20M | $12.80M | $12.90M | $5.30M | $11.80M | +3.1% |
| Stock-based compensation | $4.20M | $5.70M | $5.90M | $9.50M | $5.90M | -26.3% |
| Change in working capital | -$2.30M | $7.90M | -$40.90M | $24.10M | $9.10M | -129.1% |
| Operating cash flow | $41.80M | $31.10M | $17.20M | $84.00M | $81.20M | +34.4% |
| Capital expenditure | -$1.10M | -$500.00K | -$600.00K | -$7.30M | -$400.00K | -120.0% |
| Investing cash flow | -$129.50M | -$500.00K | $9.50M | -$7.30M | -$400.00K | -25,800.0% |
| Dividends paid | -$600.00K | -$8.90M | -$8.90M | -$8.80M | -$8.70M | +93.3% |
| Financing cash flow | $112.40M | -$41.50M | -$51.60M | -$81.60M | -$62.60M | +370.8% |
| Free cash flow | $40.70M | $30.60M | $16.60M | $76.70M | $80.80M | +33.0% |
| End cash position | $218.20M | $193.40M | $204.40M | $228.60M | $233.60M | +12.8% |
Options analytics
Put / call volume
1.56
Put-heavy session
Put / call open interest
1.61
Positioning, not flow
Max pain
5.00
-16.0% from spot
ATM implied vol
0.0%
Nearest strike to spot
Skew (10% OTM)
-25.0%
Calls bid over puts
Call volume
18
Contracts, this expiry
Put volume
28
Contracts, this expiry
Heaviest call OI
5.00
29 contracts
Heaviest put OI
5.00
75 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.27 | 0.56 | +111.3% |
| Mar 2026 | 0.42 | 0.27 | -35.3% |
| Dec 2025 | 0.67 | 0.71 | +6.0% |
| Sep 2025 | 0.46 | 0.50 | +9.9% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.29 | 4 | $269.72M | +2.4% |
| Next quarter | 0.49 | 3 | $268.02M | +2.6% |
| Current year | 1.84 | 4 | $1.02B | -5.1% |
| Next year | 1.76 | 4 | $1.08B | +5.6% |
Analyst targets & ownership
Mean target$4.00
High target$5.00
Low target$3.00
Implied upside-32.77%
Analyst count2
ConsensusNONE
Strong buy / Buy0 / 0
Hold3
Sell / Strong sell0 / 1
Held by insiders2.01%
Held by institutions91.40%
Institutions holding434
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
5.77
+3.08% from price
SMA 20
5.48
+8.68% from price
SMA 50
5.05
+17.87% from price
SMA 100
4.15
+43.53% from price
SMA 200
6.96
-14.54% from price
EMA 12
5.70
+4.38% from price
EMA 26
5.46
+8.91% from price
EMA 50
5.14
+15.71% from price
RSI (14)
64.0
Neutral
MACD (12,26,9)
0.24
Hist 0.01
ATR (14)
0.27
4.51% of price
Realised vol 30D
51.8%
Annualised
Bollinger upper
6.15
20, 2σ
Bollinger lower
4.80
20, 2σ
50 / 200 cross
Death
5.05 vs 6.96
Trend bias
Below 200
-14.54%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.42
Less volatile than market
Correlation to SPY
0.07
Largely independent
Realised vol 30D
51.8%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-80.2%
Peak to trough
Max drawdown 5Y
-93.8%
Peak to trough
ATR 14
0.27
4.51% of price
Beta (reported)
0.83
5Y monthly, from filing
Short interest
Shares short
5.55M
Prior 5.44M
Change vs prior
+1.9%
Shorts adding
% of float
11.77%
Elevated
% of shares out
9.79%
Against total outstanding
Days to cover
4.2
Liquid
Float
54.77M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| May 18, 26 | B of A Securities | MAINTAINED | Underperform | Underperform |
| May 6, 26 | Mizuho | MAINTAINED | Neutral | Neutral |
| May 6, 26 | BTIG | DOWNGRADE | Buy | Neutral |
| Apr 13, 26 | Mizuho | MAINTAINED | Neutral | Neutral |
| Feb 6, 26 | BTIG | MAINTAINED | Buy | Buy |
| Sep 5, 25 | BTIG | MAINTAINED | Buy | Buy |
| Jul 16, 25 | Mizuho | MAINTAINED | Neutral | Neutral |
| May 23, 25 | Mizuho | MAINTAINED | Neutral | Neutral |
| Apr 10, 25 | Mizuho | INITIATED | — | Neutral |
| Nov 27, 24 | BTIG | UPGRADE | Neutral | Buy |
| Jul 15, 24 | Morgan Stanley | MAINTAINED | Underweight | Underweight |
| May 10, 24 | Morgan Stanley | MAINTAINED | Underweight | Underweight |
Dividends & splits
Forward rate$0.04 / yr
Forward yield0.67%
5-year avg yield2.33%
Payout ratio31.29%
Ex-dividend dateAug 27, 2026
Next pay dateSep 15, 2026
Last split—
Split date—
SEC filings
Periodic Financial Reports
10-Q · 2026-08-07
Corporate Changes & Voting Matters
8-K/A · 2026-07-31
Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)
SD · 2026-05-22
Corporate Changes & Voting Matters
8-K · 2026-05-15
Periodic Financial Reports
10-Q · 2026-05-05
Corporate Changes & Voting Matters
8-K · 2026-03-20
Corporate Changes & Voting Matters
8-K · 2026-02-13
Periodic Financial Reports
10-Q · 2026-02-05
Headlines
embecta to Participate in Investor Events
GlobeNewswire · 37d ago
Embecta (EMBC) Q3 2026 Earnings Call Transcript
Motley Fool · 54d ago
Embecta Corp. Q3 2026 Earnings Call Summary
Moby · 60d ago
Embecta Corp (EMBC) (Q3 2026) Earnings Call Highlights: Strong Sequential Recovery and Raised ...
GuruFocus.com · 61d ago
Embecta Q3 Earnings Call Highlights
MarketBeat · 61d ago
Embecta Corp. Reports Third Quarter Fiscal 2026 Financial Results
GlobeNewswire · 61d ago
embecta Announces Quarterly Cash Dividend
GlobeNewswire · 61d ago
embecta to Report Fiscal Third Quarter Financial Results
GlobeNewswire · 76d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.